Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Arnaud

Showing results (161-170 of 203) with videos related to

Pageof 21
Sort By:
The Journal of Clinical Investigation|July 1, 1972
Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosisB L Riggs, J Jowsey, R S Goldsmith, et al.
The Journal of Clinical Investigation|January 1, 1973
Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. 3. Evaluation of parathyroid suppressibilityR S Goldsmith, J Furszyfer, W J Johnson, et al.
Biological & Pharmaceutical Bulletin|April 29, 1999
Stable human calcitonin analogues with high potency on bone together with reduced anorectic and renal actionsK Uda, Y Kobayashi, T Hisada, et al.
Genomics|April 1, 1988
Conservation and reorganization of loci on the mammalian X chromosome: a molecular framework for the identification of homologous subchromosomal regions in man and mouseL C Amar, L Dandolo, A Hanauer, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1976
Effects of phosphorus supplementation on serum parathyroid hormone and bone morphology in osteoporosisR S Goldsmith, J Jowsey, W J Dubé, et al.
CA: a Cancer Journal for Clinicians|January 1, 1975
Hypercalcemia and cancerD A Scholz, D C Purnell, R S Goldsmith, et al.
The American Journal of Medicine|June 1, 1974
Prevention and reversal of progressive secondary hyperparathyroidism in patients maintained by hemodialysisW J Johnson, R S Goldsmith, J W Beabout, et al.
Endocrinology|December 1, 1988
Structural properties of the renal parathyroid hormone receptor: hydrodynamic analysis and protease sensitivityD B Karpf, C D Arnaud, T Bambino, et al.
Mayo Clinic Proceedings|February 1, 1972
Successful medical management of osteitis fibrosa due to "tertiary" hyperparathyroidismW M Vosik, C F Anderson, W P Steffee, et al.
The Journal of Clinical Investigation|March 1, 1971
Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. I. Association of bone disease with potentially etiologic factorsA E Fournier, W J Johnson, D R Taves, et al.
Pageof 21

Showing results (161-170 of 203) with videos related to

Sort By:
Pageof 21
The Journal of Clinical Investigation|July 1, 1972
Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosisB L Riggs, J Jowsey, R S Goldsmith, et al.
The Journal of Clinical Investigation|January 1, 1973
Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. 3. Evaluation of parathyroid suppressibilityR S Goldsmith, J Furszyfer, W J Johnson, et al.
Biological & Pharmaceutical Bulletin|April 29, 1999
Stable human calcitonin analogues with high potency on bone together with reduced anorectic and renal actionsK Uda, Y Kobayashi, T Hisada, et al.
Genomics|April 1, 1988
Conservation and reorganization of loci on the mammalian X chromosome: a molecular framework for the identification of homologous subchromosomal regions in man and mouseL C Amar, L Dandolo, A Hanauer, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1976
Effects of phosphorus supplementation on serum parathyroid hormone and bone morphology in osteoporosisR S Goldsmith, J Jowsey, W J Dubé, et al.
CA: a Cancer Journal for Clinicians|January 1, 1975
Hypercalcemia and cancerD A Scholz, D C Purnell, R S Goldsmith, et al.
The American Journal of Medicine|June 1, 1974
Prevention and reversal of progressive secondary hyperparathyroidism in patients maintained by hemodialysisW J Johnson, R S Goldsmith, J W Beabout, et al.
Endocrinology|December 1, 1988
Structural properties of the renal parathyroid hormone receptor: hydrodynamic analysis and protease sensitivityD B Karpf, C D Arnaud, T Bambino, et al.
Mayo Clinic Proceedings|February 1, 1972
Successful medical management of osteitis fibrosa due to "tertiary" hyperparathyroidismW M Vosik, C F Anderson, W P Steffee, et al.
The Journal of Clinical Investigation|March 1, 1971
Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. I. Association of bone disease with potentially etiologic factorsA E Fournier, W J Johnson, D R Taves, et al.
Pageof 21